These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Changes in Management After Ng M; Guerrieri M; Wong LM; Taubman K; Sutherland T; Benson A; Byrne G; Koschel S; Yap K; Starmans M; Ong G; Macleod C; Foo M; Chao M J Nucl Med; 2022 Sep; 63(9):1343-1348. PubMed ID: 35058320 [TBL] [Abstract][Full Text] [Related]
5. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for Kim EH; Siegel BA; Teoh EJ; Andriole GL; Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848 [TBL] [Abstract][Full Text] [Related]
6. A Multicenter Prospective Clinical Trial of McCarthy M; Francis R; Tang C; Watts J; Campbell A Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):801-808. PubMed ID: 30890448 [TBL] [Abstract][Full Text] [Related]
7. 3-Year Freedom from Progression After Emmett L; Tang R; Nandurkar R; Hruby G; Roach P; Watts JA; Cusick T; Kneebone A; Ho B; Chan L; van Leeuwen PJ; Scheltema MJ; Nguyen A; Yin C; Scott A; Tang C; McCarthy M; Fullard K; Roberts M; Francis R; Stricker P J Nucl Med; 2020 Jun; 61(6):866-872. PubMed ID: 31676727 [No Abstract] [Full Text] [Related]
8. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
9. A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. Liu W; Zukotynski K; Emmett L; Chung HT; Chung P; Wolfson R; Rachinsky I; Kapoor A; Metser U; Loblaw A; Morton G; Sexton T; Lock M; Helou J; Berlin A; Boylan C; Archer S; Pond GR; Bauman G Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):546-555. PubMed ID: 31730876 [TBL] [Abstract][Full Text] [Related]
12. Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774). Armstrong WR; Kishan AU; Booker KM; Grogan TR; Elashoff D; Lam EC; Clark KJ; Steinberg ML; Fendler WP; Hope TA; Nickols NG; Czernin J; Calais J Eur Urol; 2024 Jul; 86(1):52-60. PubMed ID: 38290964 [TBL] [Abstract][Full Text] [Related]
13. Detection Rate of PSMA PET Using Different Ligands in Men with Biochemical Recurrent Prostate Cancer Following Radical Treatment: A Systematic Review and Meta-analysis of Prospective Studies. Wu Q; Bates A; Guntur P; Shamim SA; Nabi G Acad Radiol; 2024 Feb; 31(2):544-563. PubMed ID: 37770370 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Performance of Morris MJ; Rowe SP; Gorin MA; Saperstein L; Pouliot F; Josephson D; Wong JYC; Pantel AR; Cho SY; Gage KL; Piert M; Iagaru A; Pollard JH; Wong V; Jensen J; Lin T; Stambler N; Carroll PR; Siegel BA; Clin Cancer Res; 2021 Jul; 27(13):3674-3682. PubMed ID: 33622706 [TBL] [Abstract][Full Text] [Related]
16. Patterns of disease detection using [ Koschel S; Taubman K; Sutherland T; Yap K; Chao M; Guerrieri M; Benson A; Starmans M; Byrne G; Ong G; Macleod C; Foo M; Wong LM; Gyomber D; Ng M Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3712-3722. PubMed ID: 33852051 [TBL] [Abstract][Full Text] [Related]